UiPath (NYSE:PATH) Trading 0.5% Higher

UiPath Inc. (NYSE:PATH) traded up 0.5% on Wednesday . The stock traded as high as $19.91 and last traded at $19.65. 1,215,390 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 8,732,511 shares. The stock had previously closed at $19.55.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Royal Bank of Canada restated a “sector perform” rating and issued a $29.00 price objective on shares of UiPath in a report on Monday, April 1st. Morgan Stanley increased their target price on shares of UiPath from $17.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, March 14th. Truist Financial reiterated a “buy” rating and issued a $32.00 target price on shares of UiPath in a report on Wednesday, March 20th. TD Cowen increased their target price on shares of UiPath from $25.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday, March 14th. Finally, William Blair began coverage on shares of UiPath in a report on Tuesday, January 2nd. They issued an “outperform” rating on the stock. Nine investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, UiPath has an average rating of “Moderate Buy” and an average target price of $27.41.

UiPath Price Performance

The firm has a market cap of $11.14 billion, a P/E ratio of -114.20 and a beta of 0.96. The business’s 50-day moving average is $22.30 and its two-hundred day moving average is $21.53.

UiPath (NYSE:PATH) last released its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.10. The business had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. Equities research analysts predict that UiPath Inc. will post -0.04 EPS for the current year.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction on Friday, March 15th. The shares were sold at an average price of $22.84, for a total value of $365,440.00. Following the completion of the transaction, the chief financial officer now owns 87,505 shares of the company’s stock, valued at $1,998,614.20. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Over the last 90 days, insiders sold 72,000 shares of company stock valued at $1,591,360. Corporate insiders own 31.03% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of PATH. Mark Sheptoff Financial Planning LLC bought a new position in shares of UiPath in the 4th quarter valued at about $25,000. HighMark Wealth Management LLC acquired a new position in UiPath in the 4th quarter valued at about $27,000. Cypress Capital Management LLC WY acquired a new position in UiPath in the 4th quarter valued at about $29,000. Fifth Third Bancorp grew its stake in UiPath by 2,005.3% in the 3rd quarter. Fifth Third Bancorp now owns 2,000 shares of the healthcare company’s stock valued at $34,000 after buying an additional 1,905 shares during the last quarter. Finally, GAMMA Investing LLC acquired a new position in UiPath in the 4th quarter valued at about $36,000. Institutional investors own 62.50% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.